Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer — Stella

Recruiting

Back to Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah

Key details

Phase

Safety & dosing

Sponsor

University of Utah

Enrollment target

~160 participants

Started

October 2025

Primary completion

October 2030

Age range

18 Years and older

Sex

Male only

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov